Kappac Pharma Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 20	Mar ' 18	Mar ' 17	Mar ' 16	Mar ' 15

Sources of funds

Owner's fund

Equity share capital

30.27

30.27

30.27

30.27

30.27

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

6.03

7.69

7.70

7.74

7.77

Loan funds

Secured loans

-

0.20

-

-

-

Unsecured loans

-

-

-

-

-

Total

36.29

38.16

37.96

38.01

38.03

Uses of funds

Fixed assets

Gross block

-

-

-

-

-

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

-

-

-

-

Net block

-

-

-

-

-

Capital work-in-progress

-

-

-

-

-

Investments

11.46

37.99

37.99

38.01

38.01

Net current assets

Current assets, loans & advances

24.89

0.22

0.02

0.03

0.03

Less : current liabilities & provisions

0.06

0.05

0.05

0.03

0.01

Total net current assets

24.83

0.17

-0.03

-

0.02

Miscellaneous expenses not written

-

-

-

-

-

Total

36.29

38.16

37.96

38.01

38.03

Notes:

Book value of unquoted investments

-

-

29.31

29.31

29.70

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

302.65

302.65

302.65

302.65

302.65